The dietary management of patients with diabetes and renal disease: Challenges and practicalities

Journal of Renal Care

Volumn 38, Issue SUPPL. 1, 2012, Pages 40-51

  Willingham, Fiona ^a  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

Author keywords

Advice; Chronic kidney disease; Diabetes; Nutrition

Indexed keywords

POTASSIUM;

ARTICLE; BODY WEIGHT; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIET THERAPY; HUMAN; LIFESTYLE; PROTEIN INTAKE;

BODY WEIGHT; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DIETARY PROTEINS; HUMANS; KIDNEY FAILURE, CHRONIC; LIFE STYLE; POTASSIUM; RENAL INSUFFICIENCY, CHRONIC;

EID: 84856923231     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2012.00283.x     Document Type: Article

References (90)

1. Alberti K.G., Zimmet P. & Shaw J. (2005). The metabolic syndrome: a new worldwide definition. Lancet 366, 1059-1062.
2. American Diabetes Association. (2011). Standards of medical care in diabetes-2011. Diabetes Care 34(Suppl 1), S11-S61.
3. Anderson J.W., Konz E.C., Frederich R.C. et al (2002). Long term weight loss maintenance: a meta-analysis of US studies. American Journal of Clinical Nutrition 74, 579-584.
4. Ashurst I. & Dobbie H. (2003). A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients. Journal of Renal Nutrition 13(4), 267-274.
5. Astrup A., Grunwald G.K., Melanson E.L. et al (2001). The role of low-fat diets in the body weight control: a meta-analysis of ad libitum dietary intervention studies. International Journal of Obesity 24, 1545-1552.
6. Balkau B., Charles M.A., Drivsholm T. et al (2002). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes and Metabolism 28, 364-376.
7. Bibbins-Domingo K., Chertow G.M., Coxson P.G. et al (2010). Projected effect of dietary salt reductions on future cardiovascular disease. The New England Journal of Medicine 362, 590-599.
8. Block G., Klassen P., Lazarus J. et al (2004). Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. Journal of the American Society of Nephrology 15, 2208-2218.
9. Brenner B.M., Meyer T.W. & Hostetter T.H. (1982). Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. The New England Journal of Medicine 307(11), 652-659.
10. British Dietetic Association Renal Nutrition Group. (2011). Evidence Based Dietetic Guidelines: Protein Requirements of Adults on Haemodialysis and Peritoneal Dialysis.
11. Chagnac A., Weinstein T., Herman M. et al (2003). The effects of weight loss on renal function in patients with severe obesity. Journal of the American Society of Nephrology 14, 1480-1486.
12. Combe C. & Aparicio M. (1994). Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney International 46, 1381-1386.
13. Cook S., MacLaughlin H. & MacDougall I.C. (2008). A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease. Nephrology Dialysis Transplantation 23, 263-268.
14. Covic A., Kothawala P., Bernal M. et al (2009). Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrology Dialysis Transplantation 24, 1506-1523.
15. Department of Health. (2001). The National Service Framework for Diabetes. (accessed 6 June 2011).
16. Department of Health. (2009). Blood Pressure. (Accessed 6 June 2011).
17. Department of Health and Diabetes UK Joint Report. (2006). Care Planning in Diabetes.
18. Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 329, 977-986.
19. Diabetes UK. (2008). Position paper on vascular risk factors.
20. Dhingra R., Sullivan L., Fox C.S. et al (2007). Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Archives of Internal Medicine 167, 879-884.
21. Dwyer J.T., Larvine B., Leung J. et al (2005). Are nutritional status indicators associated with mortality in the hemodialysis (HEMO) study? Kidney International 68, 1766-1776.
22. Eckel R.H. (2008). Clinical practice. Non-surgical management of obesity in adults. The New England Journal of Medicine 358, 1941-1950.
23. Ejerblad E., Fored C.M., Lindblad P. et al (2006). Obesity and risk for chronic renal failure. Journal of the American Society of Nephrology 17, 1695-1702.
24. Elsayed E.F., Tighiouart H., Weiner D.E. et al (2008). Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. American Journal of Kidney Diseases 52, 49-57.
25. Evans M., Fryzek J.P., Elinder C.G. et al (2005). The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. American Journal of Kidney Diseases 46, 863-870.
26. Food Standards Agency. (2011). Salt. (Accessed 3 June 2011).
27. Fouque D. & Lavill M. (2009). Low protein diets for chronic kidney disease in non diabetic adults (Review). The Cochrane Collaboration.
28. Fouque D., Pelletier S., Mafra D. et al (2011). Nutrition and chronic kidney disease. Kidney International 80, 348-357.
29. Fouque D., Vennegoor M., Wee P.T. et al.(2007). EBPG guideline on nutrition. Nephrology Dialysis Transplantation 22, ii45-ii87.
30. Gaede P., Vdel P., Larsen N. et al (2003). Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England Journal of Medicine 348(5), 383-393.
31. Goldstein D.J. (1992). Beneficial health effects of modest weight loss. International Journal of Obesity and Related Metabolic Disorders 16, 397-415.
32. Harnden K.E., Frayn K.N. & Hodson L. (2010). Dietary Approaches to Stop Hypertension (DASH) diet: applicability and acceptability to a UK population. Journal of Human Nutrition and Dietetics 23(1), 3-10.
33. He F.J. & MacGregor G.A. (2002). Effect of modest salt reduction on blood pressure: a meta-analysis of randomised trials. Implications for public health. Journal of Human Hypertension 16, 761-770.
34. He F.J. & MacGregor G.A. (2003). How far should salt intake be reduced? Hypertension 42, 1093-1099.
35. He F.J. & MacGregor G.A. (2005). Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension. Hypertension 46, 66-70.
36. He F.J. & MacGregor G.A. (2009). A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. Journal of Human Hypertension 23, 363-384.
37. Hsu C.Y. & Chertow G.M. (2002). Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrology Dialysis Transplantation 17, 1419-1425.
38. Hsu C., McCulloch C.E., Iribarren C. et al (2006). Body mass index and risk for end-stage renal disease. Annals of Internal Medicine 144, 21-28.
39. Johansen K.L., Young B., Kaysen G.A. et al (2004). Association of body size with outcomes among patients beginning dialysis. The American Journal of Clinical Nutrition 80, 324-332.
40. Jones-Burton C., Mishra S.I., Fink J.C. et al (2006). An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. American Journal of Nephrology 26, 268-275.
41. Klahr S., Levey A.S., Beck G.J. et al (1994). For the Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. The New England Journal of Medicine 330(13), 877-884.
42. Klein S., Sheard N.F., Pi-Sunyer X. et al (2004). Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. Diabetes Care 27(8), 2067-2073.
43. Knowler, Stratton R.J., Bircher G., Rouque D. et al (2002). Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine 346(6), 393-403.
44. Koppell K.J., Kataoka M., Williams S.M. et al (2010). Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment-Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial. BMJ 341, 3337-43.
45. Leavey S., McCullough K., Hecking E. et al (2001). Body mass index and mortality in 'healthier' as compared with 'sicker' haemodial-ysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation 16, 2386-2394.
46. Locatelli F., Fouque D., Heimburger O. et al (2002). Nutritional status in dialysis patients: a European consensus. Nephrology Dialysis Transplantation 17, 563-572.
47. Look AHEAD Research Study Group. (2007). Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 30: 1374-83.
48. Mann J.I., De Leeuw I., Hermansen K. et al (2004). Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutrition Metabolism and Cardiovascular Diseases 14, 373-394.
49. Morales E., Valero M.A., Leon M. et al (2003). Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases 41, 319-327.
50. Moranne O., Froissart M., Rossert J. et al (2009). Timing of onset of CKD-related metabolic complications. Journal of the American Society of Nephrology 20, 164-167.
51. Nathan D.M., Buse J.B., Davidson M.B. et al (2009). Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes). Diabetologia 52, 17-30.
52. National Collaborating Centre for Chronic Conditions-on behalf of NICE. (2008). Type 2 Diabetes - National Clinical Guideline for Management in Primary and Secondary Care (Update). London : Royal College of Physicians.
53. National Diet and Food Survey. (2010). (accessed June 2011).
54. National Institute for Clinical Excellence. (2008). Chronic kidney disease - early identification and management of chronic kidney disease in adults in primary and secondary care. NICE Clinical Guideline 73.
55. National Institute for Clinical Excellence. (2011). Preventing type 2 diabetes: population and community interventions. NICE Public Health Guidance 35.
56. Navaneethan S.D., Yehnert H., Moustarah F. et al (2009). Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of the American Society of Nephrology 4, 1565-1574.
57. Neter J.E., Stam B.E., Kok F.J. et al (2003). Influence of weight reduction on blood pressure: a meta analysis of randomised controlled trials. Hypertension 42, 878-884.
58. NHS Choices. (2011). EatWell plate. (accessed 29 November 2011).
59. Nutritional Subcommittee of the Diabetes Care Advisory Committee of Diabetes U.K. (2003). The implementation of nutritional advice for people with diabetes. Diabetes Medicine 20, 786-807.
60. Nyirenda M.J., Tang J.I., Padfield P.L. et al (2009). Hyperkalaemia. BMJ 339, b4114.
61. Paffenberger R.S. Jr., Hyde R.T., Wing A.L. et al (1993). The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. The New England Journal of Medicine 328, 538-545.
62. Pifer T.B., McCullough K.P, Port F.K. et al (2002). Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney International 62, 2238-2245.
63. Raptis A.E., and Viberti G. (2001). Pathogenesis of Diabetic Nephropathy. Exp. Clin. Endocrinol. Diabetes 109(Suppl 2): 5424-37.
64. Reddy V., Symes F., Sethi N. et al (2009). Dietitian-led education program to improve phosphate control in a single-center hemodial-ysis population. Journal of Renal Nutrition 19(4), 314-320.
65. Renal Association. (2010a). 13th Report of the UK Renal Registry. (Accessed 30 May 2011).
66. Renal Association. (2010b). Nutrition in CKD Clinical Practice Guidelines. (Accessed 14 June 2011).
67. Renal Association. (2011). Chronic Kidney Disease Clinical Practice Guidelines. (Accessed 14 June 2011).
68. Robertson L.M., Waugh N. & Robertson A. (2009). Protein restriction for diabetic renal disease (review). The Cochrane Collaboration.
69. Ryu S., Chang Y, Woo H.Y et al (2008). Changes in body weight predict CKD in healthy men. Journal of the American Society of Nephrology 1(9), 1798-1805
70. Sacks F.M., Svetkey L.P., Vollmer W.M. et al (2001). For the DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. The New England Journal of Medicine 344(1), 3-10
71. Savica V, Calo L.A., Monardo P. et al (2009). Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia. Journal of Renal Nutrition 1(9), 69-72
72. Shinaberger C.S., Greenland S., Kopple J.D. et al (2008). Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? American Journal of Clinical Nutrition 88, 1511-1518
73. Scottish Intercollegiate Guidelines Network (SIGN) Guideline 116. (2010) Management of Diabetes - A National Clinical Guideline. ISBN 978 1 905813 58 2.
74. Slagman M.C.J., Waanders F., Hemmelder M.H. et al (2011) Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lower-ng proteinuria and blood pressure: randomised controlled trial. BMJ 343, d4366.
75. Stratton R.J., Bircher G., Fouque et al. (2005). Multinutrient oral supplements & tube feeding in maintenance dialysis: a systematic review & meta-analysis. American Journal of Kidney Diseases 46(3), 387-405
76. Sullivan CM., Leon J.B. & Sehgal A.R. (2007). Phosphorus-contain-ng food additives and the accuracy of nutrient databases mplications for renal patients. Journal of Renal Nutrition 1(7), 350-354
77. The National Health and Nutrition Examination Survey NHANES. (2008) (accessed May 2011).
78. Thijssen D.H., Maiorana A.J., O'Driscoll G. et al (2010). Impact of inactivity and exercise on the vasculature in humans. European Journal of Applied Physiology 1(08), 845-875
79. Ting S.M.S., Nair H., Ching I. et al (2009). Overweight, obesity and chronic kidney disease. Nephron Clinical Practice 112, c121-127.
80. Tonelli M., Pannu N. & Manns B. (2010). Oral phosphate binders in patients with kidney failure. The New England Journal of Medicine 362, 1312-1324.
81. Tong P., Luk A., So W.Y. et al (2008). Metabolic syndrome predicts new onset of chronic kidney disease in 5, 829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 31, 2357-2361.
82. Tuomilehto J., Lindstrom J., Eriksson J.G. et al (2001). (for the Finnish Diabetes Prevention Study Group). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine 344(18), 1343-1350.
83. United Kingdom Prospective Diabetes Study Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853.
84. United States Department of Agriculture. (2011). MyPlate. (accessed 29 November 2011).
85. United States Renal Data System. (2010). USRD 2008 Annual Report.
86. Vollmer W.M., Sacks F.M., Ard J. et al (2001). Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Annals of Internal Medicine 135, 1019-1028.
87. Wang Y., Chen X., Song Y. et al (2008). Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney International 73, 19-33.
88. World Health Organization. (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland : World Health Organization.
89. World Health Organization. (2003). Screening for Type 2 Diabetes: Report of a World Health Organization and International Diabetes Federation Meeting. Geneva : Department of Noncommunicable Disease Management, World Health Organization.
90. World Health Organization. (2011). Diabetes - Fact sheet 312. Available at: (Accessed 30 December 2011)